Study on Bisphosphonates Targeting Triple-negative Breast Cancer
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: Zoledronic Acid
Sponsor: Shengjing Hospital
Collaborators: Liaoning Tumor Hospital & Institute|The People's Hospital of Liaoning Province